Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Holdings in company

Advanced Oncotherapy (AVO) – Holdings in company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights :

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:
iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)
(if different from 3.):iv

Registered Holder:

Available on Request                                          7,068*

Chase (GA Group) Nominees Limited        1,474,892*

HSBC Global Custody Nominee (UK) Limited                                                                                                          328,573*

*denotes direct interest

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

28 April 2017

6. Date on which issuer notified:

2 May 2017

7. Threshold(s) that is/are crossed or
reached:
vi, vii

3% to <3% Change at Direct Interest Level (Box 8A)

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares    GBP 0.25

GB00BD6SX109

3,247,036

3,247,036

1,810,533

1,810,533

**Not disclosable

2.44%

Not disclosable

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

RIGHT TO RECALL LOANED SHARES

 

N/A

N/A

485,960*

 

*Direct Interest

0.66%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,296,493

3.10%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

·      Aviva plc (Parent Company)

·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Friends Provident International Limited:

·      Aviva plc (Parent Company)

·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

·      Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:


13. Additional information:

Figures are based on a total number of voting rights of 74,156,188 as per the Company’s ‘Conversion of Convertible Loan Notes’ announcement of 18th April 2017.

** Although not reportable, as per DTR5.1.5,the non-disclosable (indirect) position is currently 865,438 shares, and is included here in the interests of transparency.

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

01603 684420


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.